We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCFT icon
2276
MasterCraft Boat Holdings
MCFT
$590M
$2.34M ﹤0.01%
90,280
+32,632
+57% +$770K
ULCC icon
2277
Frontier Group Holdings
ULCC
$1.7B
$2.33M ﹤0.01%
227,322
+122,224
+116% +$1.42M
ARIS
2278
DELISTED
Aris Water Solutions
ARIS
$2.33M ﹤0.01%
161,901
-68,678
-30% -$1.05M
IMAX icon
2279
IMAX
IMAX
$2.66B
$2.33M ﹤0.01%
159,064
-13,765
-8% -$201K
CCB icon
2280
Coastal Financial
CCB
$693M
$2.32M ﹤0.01%
48,900
-9,460
-16% -$438K
RVLV icon
2281
Revolve Group
RVLV
$1.73B
$2.32M ﹤0.01%
104,419
-5,218
-5% -$125K
RKLB icon
2282
Rocket Lab Corp
RKLB
$51.8B
$2.32M ﹤0.01%
616,272
-73,363
-11% -$320K
KNSA icon
2283
Kiniksa Pharmaceuticals
KNSA
$5.93B
$2.31M ﹤0.01%
154,318
+50,931
+49% +$742K
RWT
2284
Redwood Trust
RWT
$594M
$2.31M ﹤0.01%
341,896
-51,663
-13% -$361K
NX icon
2285
Quanex
NX
$1.01B
$2.31M ﹤0.01%
97,458
-26,625
-21% -$599K
DHIL
2286
DELISTED
Diamond Hill
DHIL
$2.31M ﹤0.01%
12,466
-748
-6% -$133K
AGNT
2287
AGNT Inc
AGNT
$734M
$2.31M ﹤0.01%
208,102
-43,055
-17% -$522K
ALTG icon
2288
Alta Equipment Group
ALTG
$245M
$2.3M ﹤0.01%
174,330
-20,060
-10% -$242K
CBL
2289
CBL Properties
CBL
$1.75B
$2.3M ﹤0.01%
80,546
-33,963
-30% -$916K
WASH icon
2290
Washington Trust Bancorp
WASH
$741M
$2.3M ﹤0.01%
48,684
-9,491
-16% -$457K
UBS icon
2291
UBS Group
UBS
$176B
$2.29M ﹤0.01%
122,639
-4,799
-4% -$81.6K
NABL icon
2292
N-able
NABL
$940M
$2.29M ﹤0.01%
222,391
-15,489
-7% -$165K
LTH icon
2293
Life Time Group Holdings
LTH
$9.79B
$2.28M ﹤0.01%
190,990
-19,035
-9% -$217K
EGRX
2294
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.28M ﹤0.01%
77,932
+13,013
+20% +$414K
OPTU
2295
Optimum Communications Inc
OPTU
$301M
$2.27M ﹤0.01%
494,537
-39,859
-7% -$196K
BCOV
2296
DELISTED
Brightcove, Inc.
BCOV
$2.27M ﹤0.01%
434,441
-49,948
-10% -$291K
PLTK icon
2297
Playtika
PLTK
$1.12B
$2.26M ﹤0.01%
265,674
-4,315
-2% -$40K
SSP icon
2298
E.W. Scripps
SSP
$304M
$2.26M ﹤0.01%
171,239
-31,959
-16% -$440K
TWOU
2299
DELISTED
2U Inc
TWOU
$2.26M ﹤0.01%
12,004
-761
-6% -$151K
MMP
2300
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.26M ﹤0.01%
44,931
-21,324
-32% -$1.08M

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.